RETA peptide boom: chemical body transformation sparks moral debate

The RETA peptide promises to turn overweight bodies into ripped physiques within months, but the debate goes far beyond aesthetics

A therapeutic compound, known in fitness circles as RETA, is revolutionising the conversation about obesity. It is not Spain's self-employed social security scheme (Régimen Especial de Autónomos), but a peptide that, according to testimonials, produces radical physical changes in weeks: from severe obesity to a muscular, defined physique. The discussion has intensified after documented cases surfaced on social media, where the before-and-after is so abrupt that it generates disbelief and controversy.

Behind the phenomenon lies a fact few dispute: the main component appears to act on appetite and metabolism, suppressing hunger and cravings for ultra-processed foods. According to some sources, the effect is so powerful that it allows weight loss with hardly any exercise, although the most extreme results combine the peptide with training and a ketogenic diet. One user claimed the transformation is 90% chemistry and 10% effort, which has triggered a fierce exchange of arguments about the role of willpower.

Miracle or trap? The two sides of the debate

Some argue that RETA is a legitimate tool, comparable to wearing contact lenses or braces: artificial interventions that improve quality of life. From this perspective, the sarracena objection would be an irrational prejudice. A person who had tried diets for years without success, upon trying the peptide, lost the craving for junk food and achieved a change they considered impossible. "Hunger is not just a lack of willpower, it's chemistry," one testimony summed up.

On the other side, it is argued that the treatment does not solve the root of the problem: addictive eating behaviour and an altered metabolism. "When you come off the cycle, your stomach and your head will still be those of a fat person," one participant warned. The image of the hare and the tortoise: those who lose weight with chemistry may regain it when they stop, sometimes with interest, due to the rebound effect and gastric dilation.

Hard facts: prices, risks and alternatives

The cost of these treatments is not trivial. A similar drug (Mounjaro) costs around 300 euros per month per pen, with no coverage from Spain's public health system. It can be found cheaper on the grey market, but with uncertain potency. Against this option, some defend more traditional methods: ketogenic or carnivore diets, which they claim normalise appetite and make morbid obesity nearly impossible. "If you eat meat and animal fat, when you're full you simply don't eat any more," its advocates maintain.

Bariatric surgery, for its part, receives even harsher criticism. One account described severe complications: an operated person defecates 20 minutes after eating, with problems absorbing chronic medication. For many, surgery should be the last resort, and the peptide would be a less invasive alternative, though not free of controversy.

And what about the food industry?

Several analyses point to the obesity epidemic as a by-product of decades of biased food policy. "60% carbohydrates in conventional diets, six meals a day, a calorie deficit that doesn't satisfy... that doesn't fix the metabolic problem," one comment denounced. Insulin resistance, aggravated by ultra-processed foods and refined sugars, would be the real cause. An industry that, according to this reading, first profited from tobacco and then moved on to addictive food, always with funded studies and white-coated doctors.

What nobody yet knows is whether the RETA boom will be a turning point or a bubble. The cost, access and lack of long-term studies raise doubts. Meanwhile, the underlying debate — individual responsibility versus an obesity-promoting environment — remains unresolved. And the uncomfortable question hangs in the air: how much of our biology are we willing to chemically modify to fit an aesthetic ideal?